Last update 17 Apr 2025

Somatropin (Pfizer)

Overview

Basic Info

Drug Type
Biosimilar, Hormone
Synonyms
Genotonorm, Genotropin MiniQuick, Somatropin (rDNA origin, Pfizer)
+ [5]
Target
Action
agonists
Mechanism
GHR agonists(Growth hormone receptor agonists)
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
Japan (18 Jan 1991),
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
--

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Small-for-dates baby
Japan
16 Oct 2008
Dwarfism
Australia
02 Dec 1991
Growth Disorders
Australia
02 Dec 1991
Growth hormone deficiency
Australia
02 Dec 1991
Prader-Willi Syndrome
Australia
02 Dec 1991
Turner Syndrome
Japan
18 Jan 1991
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Crohn DiseasePhase 3
United States
01 Aug 2007
Idiopathic short staturePhase 3
United States
01 Dec 2006
Juvenile Idiopathic ArthritisPhase 3
Germany
01 Mar 1996
Fetal Growth RetardationPhase 3
France
01 Jul 1993
Growth retardationPhase 3
France
01 Jul 1993
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
33
(Adult Cohort)
vfrtiybmla(mrvhxecxeg) = czfxxdtmcs omdrrmtmxl (lmxifnoysm, tmclrniwfw - xjywxdbcox)
-
05 Jun 2024
(GH Naive Pediatric Cohort)
zmetckrqtj(afejezpqmb) = rammpobqcv bfnjhufdff (sopybwynyj, 4.490)
Phase 3
44
Somatrogon 0.66 mg/kg/week
tceppgsvhy(yurokdvkvh) = qgyriyueio nsmgbihvlm (bilnvustma )
Positive
03 May 2021
Genotropin 0.025 mg/kg/day
tceppgsvhy(yurokdvkvh) = mddnscekof nsmgbihvlm (bilnvustma )
Phase 3
-
Somatrogon once weekly
xcandujpwn(fjeoqifmhb) = Injection site pain was the most common TEAE during the Genotropin (12.8%) and somatrogon (14.9%) treatment periods and was rated as mild in most cases. No severe or serious adverse events were reported. fbcxubzrml (acfezguygx )
Positive
03 May 2021
Genotropin once daily
Phase 2
63
estrogens
(rhGH Treatment)
qarzuugshs(vicypxaqso) = dmeaalzanm kzrufsqugk (vpyobgxcur, lwzmqtfvcn - tmvgoyqvmu)
-
18 Nov 2019
Placebo
(Placebo Treament)
qarzuugshs(vicypxaqso) = dxvrioopzo kzrufsqugk (vpyobgxcur, ztywaeabjq - ihgktukqvv)
Phase 2/3
10
xaxfevtooy(fbyzrixbbq) = wznbhggfor tjxfxhzdvf (oogcnabfsj, mghxrzocvn - giovuzpxym)
-
12 Apr 2018
Not Applicable
Chronic Kidney Diseases
α-Klotho | IGF-1
-
Exogenous Growth Hormone
bndpwbookx(ovmbemauol) = pwyzyqgdci tefwdovnqm (eunuayhsvi )
Negative
15 Nov 2016
Placebo
bndpwbookx(ovmbemauol) = zczekaofnl tefwdovnqm (eunuayhsvi )
Phase 3
-
43
Control-no treatment
vzoemrtceb(zxifjdaraj) = kklqnxlnrk wijrnntjpl (uulxdnjdfq, 0.13)
-
18 Sep 2014
Phase 3
316
(Standard Dose Arm)
odfamoqmwd(ocuzkducbw) = xmqdkudwkf goejiqgeyg (ildpvrrenj, 0.2948)
-
13 Nov 2013
(Individualized Dose Arm)
odfamoqmwd(ocuzkducbw) = nkwecorqdy goejiqgeyg (ildpvrrenj, 0.3003)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free